Allurion Technologies, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Allurion Technologies, Inc. (ALUR) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$172.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-05-15
- Allurion Technologies, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$172.00K.
- Allurion Technologies, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$316.00K.
- Allurion Technologies, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$327.00K.
- Allurion Technologies, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was -$10.00K.
- Allurion Technologies, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$800.00K.
- Allurion Technologies, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$913.00K.
- Allurion Technologies, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$285.00K, a 149.39% decline from fiscal 2022.
- Allurion Technologies, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $577.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$172.00K 10-Q · filed 2026-05-15 | -$488.00K derived: sum of 2 quarters · filed 2026-05-15 | -$815.00K derived: sum of 3 quarters · filed 2026-05-15 | -$825.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -$316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$643.00K derived: sum of 2 quarters · filed 2026-03-30 | -$653.00K derived: sum of 3 quarters · filed 2026-03-30 | -$800.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$327.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$337.00K derived: sum of 2 quarters · filed 2025-11-17 | -$484.00K 10-Q · filed 2025-11-17 | -$650.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$157.00K 10-Q · filed 2025-08-19 | -$323.00K derived: sum of 3 quarters · filed 2026-05-15 | -$352.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | -$147.00K 10-Q · filed 2026-05-15 | -$313.00K derived: sum of 2 quarters · filed 2026-05-15 | -$342.00K derived: sum of 3 quarters · filed 2026-05-15 | -$816.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$195.00K derived: sum of 2 quarters · filed 2026-03-30 | -$669.00K derived: sum of 3 quarters · filed 2026-03-30 | -$913.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-17 | -$503.00K derived: sum of 2 quarters · filed 2025-11-17 | -$747.00K 10-Q · filed 2025-11-17 | -$623.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$474.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | -$718.00K 10-Q/A · filed 2025-08-28 | -$594.00K derived: sum of 3 quarters · filed 2025-08-28 | -$369.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | -$244.00K 10-Q/A · filed 2025-08-28 | -$120.00K derived: sum of 2 quarters · filed 2025-08-28 | $105.00K derived: sum of 3 quarters · filed 2025-08-28 | -$493.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | $124.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $349.00K derived: sum of 2 quarters · filed 2025-08-28 | -$249.00K derived: sum of 3 quarters · filed 2025-08-28 | -$285.00K 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $225.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28 | -$373.00K derived: sum of 2 quarters · filed 2025-08-28 | -$409.00K 10-Q/A · filed 2025-08-28 | -$606.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | -$598.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | -$634.00K 10-Q/A · filed 2025-08-28 | -$831.00K derived: sum of 3 quarters · filed 2025-08-28 | -$1.78M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | -$36.00K 10-Q/A · filed 2025-08-28 | -$233.00K derived: sum of 2 quarters · filed 2025-08-28 | -$1.19M derived: sum of 3 quarters · filed 2025-08-28 | |
| 2022-12-31 | -$197.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | -$1.15M derived: sum of 2 quarters · filed 2025-08-28 | $577.00K 10-K/A · filed 2025-08-28 | |
| 2022-09-30 | -$952.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $774.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $1.73M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |